In the genomic analysis of the primary tumor tissue of the TRACERx Renal study, the multi-region sequencing underscores intratumoral heterogeneity and validates clonal mutual exclusivity patterns associated with BAP1 and PBRM1/SETD2 [35,36]. The gene discussed is SETD2; the disease is neoplasm.